Genmab A/s
(NASDAQ) GMAB
Genmab A/s Financials at a Glance
Market Cap
$17.38B
Revenue (TTM)
$8.65B
Net Income (TTM)
$2.76B
EPS (TTM)
$1.55
P/E Ratio
18.08
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$28.20
Volume
2,039,525.529
Open
$28.13
Price
$28.20
Volume
2,039,525.529
Open
$28.13
Previous Close
$28.20
Daily Range
$28.01 - $28.31
52-Week Range
$18.89 - $35.43
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$28.20
Volume
2,039,525.529
Open
$28.13
Previous Close
$28.20
Daily Range
$28.01 - $28.31
52-Week Range
$18.89 - $35.43
GMAB News
GMAB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Genmab A/s
Industry
Biotechnology
Sector
Health CareEmployees
3,029
CEO
Jan G. J. van de Winkel, PhD
Website
www.genmab.comHeadquarters
Copenhagen, 1560, DK
GMAB Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
37%
Net Income Margin
21%
Return on Equity
18%
Return on Capital
59%
Return on Assets
30%
Earnings Yield
5.53%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$17.38B
Shares Outstanding
616.31M
Volume
2.04M
Short Interest
0.00%
Avg. Volume
1.75M
Financials (TTM)
Gross Profit
$3.41B
Operating Income
$1.25B
EBITDA
$1.32B
Operating Cash Flow
$1.19B
Capital Expenditure
$37.03M
Free Cash Flow
$1.15B
Cash & ST Invst.
$1.71B
Total Debt
$5.43B
Genmab A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.05B
-83.6%
Gross Profit
$974.05M
-84.0%
Gross Margin
92.34%
N/A
Market Cap
$17.38B
N/A
Market Cap/Employee
$6.59M
N/A
Employees
2,638
N/A
Net Income
$30.91M
-99.2%
EBITDA
$242.27M
-89.7%
Quarterly Fundamentals
Net Cash
$3.71B
-118.5%
Accounts Receivable
$1.15B
-82.8%
Inventory
$17.96M
-71.0%
Long Term Debt
$5.13B
+448.0%
Short Term Debt
$291.00M
+216.3%
Return on Assets
30.26%
N/A
Return on Invested Capital
59.45%
N/A
Free Cash Flow
$287.35M
-4.0%
Operating Cash Flow
$300.34M
-8.0%